Search Results - "Kolesár, M"

πη scattering and the resummation of vacuum fluctuation in three-flavor χPT by Kolesár, M., Novotný, J.

“…We discuss various aspects of resummed chiral perturbation theory, which was developed recently in order to consistently include the possibility of large…”
Get full text

Macrophage Repolarization as a Therapeutic Strategy for Osteosarcoma by Anand, Namrata, Peh, Keng Hee, Kolesar, Jill M

“…Macrophages are versatile immune cells and can adapt to both external stimuli and their surrounding environment. Macrophages are categorized into two major…”
Get full text

Thiazolothiazole Fluorophores Exhibiting Strong Fluorescence and Viologen-Like Reversible Electrochromism by Woodward, Alexis N, Kolesar, Justin M, Hall, Sara R, Saleh, Nemah-Allah, Jones, Daniel S, Walter, Michael G

“…The synthesis, electrochemical, and photophysical characterization of N,N′-dialkylated and N,N′-dibenzylated dipyridinium thiazolo­[5,4-d]­thiazole derivatives…”
Get full text

Prevention and treatment of chemotherapy-induced peripheral neuropathy by PICCOLO, JENNIFER, KOLESAR, JILL M

“…PURPOSEThe prevention and treatment of chemotherapy-induced peripheral neuropathy (CIPN) are reviewed. SUMMARYA number of agents, including amifostine,…”
Get full text

CCNE1 Amplification as a Predictive Biomarker of Chemotherapy Resistance in Epithelial Ovarian Cancer by Gorski, Justin W, Ueland, Frederick R, Kolesar, Jill M

“…Ovarian cancer is the most-deadly gynecologic malignancy, with greater than 14,000 women expected to succumb to the disease this year in the United States…”
Get full text

Phase III Randomized, Placebo-Controlled Trial of Docetaxel With or Without Gefitinib in Recurrent or Metastatic Head and Neck Cancer: An Eastern Cooperative Oncology Group Trial by ARGIRIS, Athanassios, GHEBREMICHAEL, Musie, GILBERT, Jill, LEE, Ju-Whei, SACHIDANANDAM, Kamakshi, KOLESAR, Jill M, BURTNESS, Barbara, FORASTIERE, Arlene A

“…We hypothesized that the addition of gefitinib, an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, to docetaxel would enhance therapeutic…”
Get full text

SYNE1 Mutation Is Associated with Increased Tumor Mutation Burden and Immune Cell Infiltration in Ovarian Cancer by Harbin, Laura M, Lin, Nan, Ueland, Frederick R, Kolesar, Jill M

“…, a nuclear envelope protein critical for cellular structure and signaling, is downregulated in numerous malignancies. alterations are found in 10% of…”
Get full text

Artesunate acts through cytochrome c to inhibit growth of pediatric AML cells by Hill, Kristen S., Schuler, Erin E., Ellingson, Sally R., Kolesar, Jill M.

“…Artesunate is a derivative of artemisinin, an active compound isolated from Artemisia annua which has been used in Traditional Chinese Medicine and to treat…”
Get full text

Lapatinib and poziotinib overcome ABCB1-mediated paclitaxel resistance in ovarian cancer by McCorkle, J Robert, Gorski, Justin W, Liu, Jinpeng, Riggs, McKayla B, McDowell, Anthony B, Lin, Nan, Wang, Chi, Ueland, Frederick R, Kolesar, Jill M

“…Conventional frontline treatment for ovarian cancer consists of successive chemotherapy cycles of paclitaxel and platinum. Despite the initial favorable…”
Get full text

Editorial: Anticancer Potential of Artemisia annua by Kolesar, Jill M, Seeberger, Peter H

Get full text

A phase I study of single-agent perifosine for recurrent or refractory pediatric CNS and solid tumors by Becher, Oren J, Millard, Nathan E, Modak, Shakeel, Kushner, Brian H, Haque, Sofia, Spasojevic, Ivan, Trippett, Tanya M, Gilheeney, Stephen W, Khakoo, Yasmin, Lyden, David C, De Braganca, Kevin C, Kolesar, Jill M, Huse, Jason T, Kramer, Kim, Cheung, Nai-Kong V, Dunkel, Ira J

“…The PI3K/Akt/mTOR signaling pathway is aberrantly activated in various pediatric tumors. We conducted a phase I study of the Akt inhibitor perifosine in…”
Get full text

EGFR testing and erlotinib use in non-small cell lung cancer patients in Kentucky by Larson, Kara L, Huang, Bin, Chen, Quan, Tucker, Thomas, Schuh, Marissa, Arnold, Susanne M, Kolesar, Jill M

“…This study determined the frequency and factors associated with EGFR testing rates and erlotinib treatment as well as associated survival outcomes in patients…”
Get full text

Clinical Outcomes of Molecular Tumor Boards: A Systematic Review by Larson, Kara L, Huang, Bin, Weiss, Heidi L, Hull, Pam, Westgate, Philip M, Miller, Rachel W, Arnold, Susanne M, Kolesar, Jill M

“…We conducted this systematic review to evaluate the clinical outcomes associated with molecular tumor board (MTB) review in patients with cancer. A systematic…”
Get more information

DACH1 mutation frequency in endometrial cancer is associated with high tumor mutation burden by Riggs, McKayla J, Lin, Nan, Wang, Chi, Piecoro, Dava W, Miller, Rachel W, Hampton, Oliver A, Rao, Mahadev, Ueland, Frederick R, Kolesar, Jill M

“…DACH1 is a transcriptional repressor and tumor suppressor gene frequently mutated in melanoma, bladder, and prostate cancer. Loss of DACH1 expression is…”
Get full text

Smoking, Sex, and Non-Small Cell Lung Cancer: Steroid Hormone Receptors in Tumor Tissue (S0424) by Cheng, Ting-Yuan David, Darke, Amy K, Redman, Mary W, Zirpoli, Gary R, Davis, Warren, Payne Ondracek, Rochelle, Bshara, Wiam, Omilian, Angela R, Kratzke, Robert, Reid, Mary E, Molina, Julian R, Kolesar, Jill M, Chen, Yuhchyau, MacRae, Robert M, Moon, James, Mack, Philip, Gandara, David R, Kelly, Karen, Santella, Regina M, Albain, Kathy S, Ambrosone, Christine B

“…To what extent steroid hormones contribute to lung cancer in male and female never smokers and smokers is unclear. We examined expression of hormone receptors…”
Get full text

Local data commons: the sleeping beauty in the community of data commons by Jeong, Jong Cheol, Hands, Isaac, Kolesar, Jill M, Rao, Mahadev, Davis, Bront, Dobyns, York, Hurt-Mueller, Joseph, Levens, Justin, Gregory, Jenny, Williams, John, Witt, Lisa, Kim, Eun Mi, Burton, Carlee, Elbiheary, Amir A, Chang, Mingguang, Durbin, Eric B

“…Abstract Background Public Data Commons (PDC) have been highlighted in the scientific literature for their capacity to collect and harmonize big data. On the…”
Get full text

Vismodegib for the treatment of basal cell skin cancer by POGGI, LAURA, KOLESAR, JILL M

“…PURPOSEThe pharmacology, clinical efficacy, adverse effects, cost, and place in therapy of vismodegib are reviewed. SUMMARYVismodegib, the first oral treatment…”
Get full text

A 3-in-1 Polymeric Micelle Nanocontainer for Poorly Water-Soluble Drugs by Shin, Ho-Chul, Alani, Adam W. G, Cho, Hyunah, Bae, Younsoo, Kolesar, Jill M, Kwon, Glen S

“…Poly(ethylene glycol)-block-poly(d,l-lactic acid) (PEG-b-PLA) micelles have a proven capacity for drug solubilization and have entered phase III clinical…”
Get full text

Next Generation Sequencing and Molecular Biomarkers in Ovarian Cancer-An Opportunity for Targeted Therapy by Harbin, Laura M, Gallion, Holly H, Allison, Derek B, Kolesar, Jill M

“…Ovarian cancer is the deadliest of all gynecologic malignancies claiming the lives of nearly 14,000 women in the United States annually. Despite therapeutic…”
Get full text

Case report: A unique presentation of a high-grade neuroepithelial tumor with EWSR1::PATZ1 fusion with diagnostic, molecular, and therapeutic insights by Ene, Andre, Di, Jing, Neltner, Janna H, Pittman, Thomas, Arnold, Susanne M, Kolesar, Jill M, Villano, John L, Bachert, Sara E, Allison, Derek B

“…EWSR1::PATZ1 fusion tumors are exceedingly rare in the central nervous system with only 14 prior cases documented. PATZ1 fusion neuroepithelial tumors are…”
Get full text